Volume 20, Issue 5, Pages (May 1998)

Slides:



Advertisements
Similar presentations
Volume 32, Issue 1, Pages (October 2008)
Advertisements

Volume 8, Issue 5, Pages (November 2001)
Apaf-1, a Human Protein Homologous to C
Autoinhibition of c-Abl
Volume 87, Issue 7, Pages (December 1996)
Volume 26, Issue 5, Pages (June 2007)
Volume 89, Issue 5, Pages (May 1997)
Volume 28, Issue 1, Pages (October 2000)
Volume 16, Issue 4, Pages (April 1996)
Volume 16, Issue 6, Pages (June 1996)
Volume 21, Issue 9, Pages (September 2013)
Dimers Probe the Assembly Status of Multimeric Membrane Proteins 
Sherilyn Grill, Valerie M. Tesmer, Jayakrishnan Nandakumar 
Volume 39, Issue 3, Pages (August 2010)
Volume 89, Issue 3, Pages (May 1997)
Volume 95, Issue 5, Pages (November 1998)
M.Brandon Parrott, Michael A. Barry  Molecular Therapy 
Lipotransin Molecular Cell
The Spinal Muscular Atrophy Disease Gene Product, SMN, and Its Associated Protein SIP1 Are in a Complex with Spliceosomal snRNP Proteins  Qing Liu, Utz.
Class C Vps Protein Complex Regulates Vacuolar SNARE Pairing and Is Required for Vesicle Docking/Fusion  Trey K. Sato, Peter Rehling, Michael R. Peterson,
SYCE2 directly binds to the chromoshadow domain of HP1α.
Volume 123, Issue 2, Pages (October 2005)
Volume 20, Issue 5, Pages (May 1998)
GRASP65, a Protein Involved in the Stacking of Golgi Cisternae
Blaise Z Peterson, Carla D DeMaria, David T Yue  Neuron 
Volume 4, Issue 2, Pages (February 1996)
A Role for Ran-GTP and Crm1 in Blocking Re-Replication
Accessory Protein Facilitated CFTR-CFTR Interaction, a Molecular Mechanism to Potentiate the Chloride Channel Activity  Shusheng Wang, Hongwen Yue, Rachel.
c-Src Activates Endonuclease-Mediated mRNA Decay
Volume 18, Issue 5, Pages (May 1997)
Volume 3, Issue 2, Pages (August 2002)
Ly6d-L, a Cell Surface Ligand for Mouse Ly6d
Frida E. Kleiman, James L. Manley  Cell 
Volume 95, Issue 5, Pages (November 1998)
Andrei Kuzmichev, Thomas Jenuwein, Paul Tempst, Danny Reinberg 
Volume 16, Issue 2, Pages (February 1996)
Volume 96, Issue 5, Pages (March 1999)
Yi-Ping Hsueh, Eunjoon Kim, Morgan Sheng  Neuron 
TopBP1 Activates the ATR-ATRIP Complex
Rab3a and SNARE Proteins: Potential Regulators of Melanosome Movement
KCNE1 Binds to the KCNQ1 Pore to Regulate Potassium Channel Activity
Volume 11, Issue 12, Pages (June 2001)
Volume 11, Issue 4, Pages (February 2001)
Silva H Hanissian, Raif S Geha  Immunity 
Phospholemman Modulates the Gating of Cardiac L-Type Calcium Channels
Volume 30, Issue 1, Pages (April 2001)
Volume 91, Issue 2, Pages (October 1997)
Takashi Hayashi, Gavin Rumbaugh, Richard L. Huganir  Neuron 
Volume 25, Issue 1, Pages (January 2000)
Bih-Hwa Shieh, Mei-Ying Zhu  Neuron 
SARA, a FYVE Domain Protein that Recruits Smad2 to the TGFβ Receptor
Volume 18, Issue 5, Pages (May 1997)
Volume 9, Issue 1, Pages (January 2002)
Volume 98, Issue 3, Pages (August 1999)
Volume 45, Issue 2, Pages (January 2005)
LAT Palmitoylation Immunity
The Structure of the GGA1-GAT Domain Reveals the Molecular Basis for ARF Binding and Membrane Association of GGAs  Brett M. Collins, Peter J. Watson,
Calcium Channel Function Regulated by the SH3-GK Module in β Subunits
Volume 20, Issue 3, Pages (March 1998)
N-Terminal Palmitoylation of PSD-95 Regulates Association with Cell Membranes and Interaction with K+ Channel Kv1.4  J.Rick Topinka, David S Bredt  Neuron 
Volume 23, Issue 2, Pages (August 2005)
SUMO-1 Protease-1 Regulates Gene Transcription through PML
Volume 19, Issue 1, Pages (July 1997)
Volume 22, Issue 3, Pages (May 2006)
Volume 2, Issue 3, Pages (September 1998)
Volume 2, Issue 2, Pages (February 2002)
Volume 91, Issue 4, Pages (November 1997)
Volume 123, Issue 2, Pages (October 2005)
Acetylation Regulates Transcription Factor Activity at Multiple Levels
Volume 113, Issue 4, Pages (May 2003)
Presentation transcript:

Volume 20, Issue 5, Pages 1017-1026 (May 1998) Primary Structure and Function of an A Kinase Anchoring Protein Associated with Calcium Channels  Peter C Gray, Barry D Johnson, Ruth E Westenbroek, Lara G Hays, John R Yates, Todd Scheuer, William A Catterall, Brian J Murphy  Neuron  Volume 20, Issue 5, Pages 1017-1026 (May 1998) DOI: 10.1016/S0896-6273(00)80482-1

Figure 1 Isolation and Cloning of AKAP15 (A) SDS-PAGE analysis of fractions collected during purification of AKAP15. Rabbit skeletal muscle microsomes (membranes), supernatant following pH 12 washing and repelleting of insoluble membranes (pH 12 wash), and resuspended pH 12–washed Triton X-100–solubilized membranes (Triton X-100 sol) were loaded in equal proportion. Triton X-100–solubilized material was loaded onto a DEAE column and the flow-through (FT), wash, and fractions collected over a gradient from 0 to 500 mM NaCl were collected. All samples were separated by SDS-PAGE, electrotransferred to nitrocellulose, and assayed for AKAP15 via the RII-biotin overlay. (B) DEAE fractions containing AKAP15 were pooled and loaded onto an RII affinity column. Pooled DEAE fractions (DEAE), flow-through (FT), wash, and AKAP15 elute samples were loaded in equal proportion, separated by SDS-PAGE, electrotransferred to nitrocellulose, and assayed for AKAP15 via the RII-biotin overlay assay. (C) A diagram illustrating the 2.2 kb cDNA encoding AKAP15. The positions of the identified open reading frame (ORF) and AP1 peptide are indicated. (D) Amino acid sequence alignment of the rat and human AKAP15 proteins. The region of the rat sequence corresponding to the AP2 peptide is indicated with a solid line, and the AP1 peptide sequence is indicated with a dashed line. The region predicted to be helical is shaded, with the amphipathic portion denoted by double bars. The N-terminal acylation domain required for membrane association is boxed with the putative acylated residues indicated by asterisks. Neuron 1998 20, 1017-1026DOI: (10.1016/S0896-6273(00)80482-1)

Figure 2 Expression and RII-Binding Properties of AKAP15 (A) GST, AKAP15 purified from rabbit skeletal muscle (AKAP15), and recombinant GST–AKAP15 samples were resolved by SDS-PAGE, electrotransferred to nitrocellulose, and visualized following treatment with either an anti-GST antibody or RII-biotin. (B) A helical wheel diagram is shown representing residues 28–41 of AKAP15 within the predicted helical domain. The hydrophobic face of the helix is shaded and the position of the L32P mutation is indicated. (C) The leucine residue at position 32 was mutated to proline via site-directed mutagenesis and the resulting mutant was expressed as a GST-fusion protein. Equivalent amounts of wild-type (GST-wt) and proline-substituted GST–AKAP15 (GST-L32P) were analyzed by Western blot probing with either anti-AP1 antibody or RII-biotin. (D) Equivalent amounts of GST–AKAP15 were resolved via SDS-PAGE, electrotransferred to nitrocellulose, and overlaid with RII-biotin preincubated without peptide (control) or with 100 nM AP2, 100 nM AP2-P, 500 nM HT31, or 500 nM HT31-P. Neuron 1998 20, 1017-1026DOI: (10.1016/S0896-6273(00)80482-1)

Figure 3 AKAP15 Is Dually Myristoylated and Palmitoylated and Requires N-Terminal Acylation for Membrane Targeting (A) Sequence comparison of residues 2–11 at the N terminus of AKAP15, Gα proteins, and src-related kinases known to be both myristoylated and palmitoylated. The residues known to be myristoylated in these proteins are boxed with light shading, while residues identified as targets of palmitoylation are indicated with dark shading. Potential acylation targets in AKAP15 are marked with asterisks. (B) AKAP15 was transiently expressed in tsA-201 cells, labeled with [3H]myristic acid or [3H]palmitic acid, immunoprecipitated, resolved via SDS-PAGE, and electrotransferred to nitrocellulose. Immunoprecipitated AKAP15 was detected via RII overlay in each case (left). In parallel experiments, nitrocellulose blots containing immunoprecipitated, labeled AKAP15 were cut into strips that were subjected directly to scintillation counting (right). (C) tsA-201 cells were transiently transfected with either wild-type or the indicated AKAP15 mutant, lysed, and subjected to a low speed spin to remove nuclei and mitochondria and then a high speed spin to separate membrane (M) and soluble (S) material. Proportional amounts of these fractions were resolved via SDS-PAGE, electrotransferred to nitrocellulose, and detected via the RII-biotin overlay. Neuron 1998 20, 1017-1026DOI: (10.1016/S0896-6273(00)80482-1)

Figure 4 Coimmunoprecipitation of AKAP15 with the L-Type Calcium Channel from Transfected Cells The membrane fraction of tsA-201 cells cotransfected with skeletal muscle L-type calcium channel subunits and AKAP15 was prepared and samples were separated via SDS-PAGE, electrotransferred to nitrocellulose, and blotted with either the anti-calcium channel antibody (CP11) or RII-biotin for detection of AKAP15. The anti-CP11 antibody was also used in immunoprecipitation experiments (CP11-IP) followed by separation of immunoprecipitated material via SDS-PAGE, electrotransfer to nitrocellulose, and RII-biotin overlay. Neuron 1998 20, 1017-1026DOI: (10.1016/S0896-6273(00)80482-1)

Figure 5 Colocalization of AKAP15 and L-Type Calcium Channels in Skeletal Muscle Transverse Tubules (A) Rat skeletal muscle tissue was stained with the anti-AKAP15 antibody anti-AP1 to detect its pattern of expression in adult rat skeletal muscle. Visualization of the staining pattern utilized a fluorescein-conjugated secondary antibody. (B) Rat skeletal muscle tissue was similarly stained with the anti-calcium channel antibody anti-CP11 and visualized using immunofluorescence following treatment with biotinylated anti-rabbit IgG and avidin conjugated to Texas red. (C) The images in (A) and (B), above, were merged to determine colocalization of AKAP15 and the calcium channel in rat skeletal muscle. Yellow immunoflourescence indicates colocalization. Scale bar = 10 μm. Neuron 1998 20, 1017-1026DOI: (10.1016/S0896-6273(00)80482-1)

Figure 6 The AKAP15-Derived Peptide AP2 Blocks Voltage-Dependent Potentiation in Intact Skeletal Muscle Cells Calcium channel current was recorded in the whole-cell patch-clamp mode from 129CB3 mouse skeletal muscle myotubes. (A) Examples of calcium channel potentiation following a conditioning prepulse in myotubes to which 100 μM AP2 peptide (AKAP15) and 200 μM AP2-P (AKAP15-P) peptides were applied through the patch pipette. The voltage-clamp protocol used to measure channel potentiation was as follows. A 300 ms test pulse is applied to −20 mV to measure channel activation under control conditions. After a 3 s recovery interval, a 200 ms conditioning prepulse is applied to +80 mV that strongly activates the calcium channel. After a brief (20 ms) recovery interval at −60 mV, a second test pulse is applied for 300 ms to −20 mV to test channel activation. The ratio of the current measured at the end of the two test pulses (after and before the conditioning prepulse) is used as the measure of channel potentiation. Test pulse currents were normalized to the same amplitudes before the prepulse to allow direct comparison of potentiation following the prepulse. Data are representative of eight and six experiments with AP2 and AP2-P peptides, respectively. (B) Mean potentiation (±SEMN = 6–8) measured as described for control and the two peptides. The absolute magnitude of the barium currents before the prepulse were similar for control (0.27 ± 0.19 pA/pF) and AP2-treated (0.24 ± 0.19 pA/pF) cells. Thus, changes in potentiation result from changes in the magnitude of the barium current after the prepulse. Neuron 1998 20, 1017-1026DOI: (10.1016/S0896-6273(00)80482-1)

Figure 7 Tissue Distribution of AKAP15 A 32P-labeled AKAP15 cDNA probe was used to detect AKAP15 messages in the tissues indicated via Northern blotting. Each lane contains 2 μg of poly A+ rat mRNA. Neuron 1998 20, 1017-1026DOI: (10.1016/S0896-6273(00)80482-1)